1353 results
Keyword Solu Medrol Remove keyword
-
List item
Press release: Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients
CMDh, Last updated: 29/06/2018Hydroxyethyl starch solutions: CMDh introduces new measures … hydroxyethyl starch (HES) solutions for infusion should remain … with these medicines. HES solutions for infusion are used to … -
List item
Press release: Marvel LifeSciences Ltd withdraws its marketing-authorisation applications for Solumarv, Isomarv medium and Combimarv (human insulin)
Last updated: 27/11/2012marketing-authorisation applications for Solumarv, Isomarv medium and Combimarv … authorisations for the medicines Solumarv, Isomarv medium and Combimarv … international units (IU)/ml solution for injection. They were … -
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021Benefits of ifosfamide solutions continue to outweigh risks … the benefits of ifosfamide solutions for infusion … the benefits of ifosfamide solutions for infusion continue to … -
List item
Core summary for product characteristics for human albumin solution
Last updated: 13/08/2018characteristics for human albumin solution … containing human albumin solution. …
-
List item
Press release: European Medicines Agency finalises review of Baxter's dialysis solutions
CHMP, Last updated: 23/09/2011review of Baxter's dialysis solutions … review of Baxter's dialysis solutions … review of Baxter’s dialysis solutions 7 Westferry Circus … -
List item
Press release: Hydroxyethyl-starch solutions for infusion to be suspended – CMDh endorses PRAC recommendation
CMDh, Last updated: 26/01/2018Hydroxyethyl-starch solutions for infusion to be suspended … hydroxyethyl-starch (HES) solutions for infusion across the European … sufficient. The review of HES solutions for infusion has been carried … -
List item
Press release: PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market
PRAC, Last updated: 12/01/2018suspending hydroxyethyl-starch solutions for infusion from the market … suspending hydroxyethyl-starch solutions for infusion from the market … suspending hydroxyethyl-starch solutions for infusion from the market … -
List item
Press release: CMDh endorses suspension of methadone oral solutions containing high molecular weight povidone
CMDh, Last updated: 24/07/2014suspension of methadone oral solutions containing high molecular … methadone oral (by mouth) solutions containing high molecular … suspension of methadone oral solutions containing povidone K90 from … -
List item
Press release: PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl starch
PRAC, Last updated: 14/06/2013authorisations for infusion solutions containing hydroxyethyl starc … the benefits of infusion solutions containing hydroxyethyl starch … medicines be suspended. Infusion solutions containing HES are medicines … -
List item
Pharmaceutical development of intravenous medicinal products containing active substances solubilised in micellar systems (non-polymeric surfactants)
Last updated: 20/03/2012containing active substances solubilised in micellar systems (non-polymeric … containing active substances solubilised in micellar systems … containing active substances solubilised in micellar systems …
-
List item
Press release: EMA recommends measures to ensure safe use of Keppra oral solution
CHMP, Last updated: 14/10/2016ensure safe use of Keppra oral solution … ensure safe use of Keppra oral solution … time each day. Take the oral solution following your doctor’s … -
List item
News: PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market
PRAC, Last updated: 11/02/2022suspending hydroxyethyl-starch solutions for infusion from the market … hydroxyethyl-starch (HES) solutions for infusion should be suspended … blood loss. The safety of HES solutions for infusion was reviewed … -
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market
CMDh, Last updated: 25/02/2022Hydroxyethyl-starch solutions for infusion recommended … hydroxyethyl-starch (HES) solutions for infusion should be suspended … blood loss. The safety of HES solutions for infusion was reviewed … -
List item
Press release: Review of the manufacture of Baxter's peritoneal dialysis solutions initiated over potential presence of endotoxins in some batches
CHMP, Last updated: 21/01/2011Baxter's peritoneal dialysis solutions initiated over potential … Baxter's peritoneal dialysis solutions initiated over potential … Art 31 peritoneal solutions Press release 7 Westferry … -
List item
Press release: European Medicines Agency recommends action plan to deal with possible presence of endotoxins in Baxter peritoneal dialysis solutions
CHMP, Last updated: 17/12/2010Baxter peritoneal dialysis solutions … their peritoneal dialysis solutions Dianeal, Extraneal and Nutrineal … Nutrineal. These are sterile solutions used in patients who have … -
List item
Lanreotide acetate, prolonged-release solution for injection in prefilled syringe 60, 90 and 120 mg product-specific bioequivalence guidance (new)
Last updated: 17/05/2022acetate, prolonged-release solution for injection in prefilled … acetate, prolonged-release solution for injection in prefilled … acetate, prolonged-release solution for 4 injection in prefilled …
-
List item
Press release: Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients – CMDh endorses PRAC recommendations
CMDh, Last updated: 25/10/2013Hydroxyethyl-starch solutions (HES) should no longer be … which concluded that HES solutions must no longer be used to … PRAC recommendation that HES solutions may continue to be used in … -
List item
Press release: PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients
PRAC, Last updated: 11/10/2013that hydroxyethyl-starch solutions (HES) should no longer be … completed its review of HES solutions following an assessment of … Committee confirmed that HES solutions must no longer be used to … -
List item
News: Medicines regulators to work together internationally to find innovative solutions to facilitate evaluation of and access to potential new medicines to counter Ebola outbreaks
Last updated: 04/09/2014internationally to find innovative solutions to facilitate evaluation … to come up with practical solutions to ensure that meaningful … internationally to find innovative solutions to facilitate evaluation … -
List item
News: Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use
Last updated: 14/02/2000Insuman Infusat 100-IU/ml solution for injection in cartridges … Insuman Infusat 100-IU/ml solution for injection in cartridges … Insuman Infusat 100IU/ml solution for injection in cartridges … -
List item
National expert: Hugues Malonne, Federal Agency for Medicines and Health Products
- Declaration of interests - 81.15 KB | PDF
- Curriculum Vitae - 35.02 KB | PDF
discoveries into new healthcare solutions. IBBL is an integrated research … hypertension 01/2016-11/2016 Pfizer Medrol Various diseases in pulmonology … -
List item
Press release: CMDh confirms that methylprednisolone injections containing lactose must not be given to patients allergic to cow's milk proteins
CMDh, Last updated: 01/08/2017of brand names including Solu-Medrol. Corticosteroids are anti-inflammatory … of brand names including Solu-Medrol. Corticosteroids are anti-inflammatory … -
List item
National expert: Andrea Margulis, European Medicines Agency
- Declaration of interests - 81.04 KB | PDF
- Curriculum Vitae - 25.21 KB | PDF
Director, Epidemiology RTI Health Solutions (Spain) Design epidemiology … Epidemiologist RTI Health Solutions (Spain) Designed epidemiology … Margulis Organisation/Company: RTI Health Solutions Country: Spain do hereby … -
List item
National expert: Tomas Arroyo Perez, Spanish Agency of Medicines and Medical Devices
- Declaration of interests - 80.61 KB | PDF
- Curriculum Vitae - 20.65 KB | PDF
FLUORSCAN 3000 MBq/ml SOLUCION INYECTABLE Fludesoxiglucose … indications FARNA-FDG 3000 MBq/ml SOLUCION INYECTABLE Fludesoxiglucose … -
List item
National expert: Yann Le Cam, European Medicines Agency
- Declaration of interests - 84.04 KB | PDF
- Curriculum Vitae - 27.7 KB | PDF
disease field that focuses on solutions to core barriers preventing … situation, elaborate new solutions and foster dialogue. Accordingly …